IntroMedic Valuation
Is A150840 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of A150840 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate A150840's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate A150840's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A150840?
Other financial metrics that can be useful for relative valuation.
What is A150840's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₩223.67b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 27.3x |
Enterprise Value/EBITDA | -38.3x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does A150840's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 2x | ||
A039840 DIO | 2.1x | 14.4% | ₩242.9b |
A206640 Boditech Med | 2.5x | 15.2% | ₩340.6b |
A100120 Vieworks | 0.9x | 10.2% | ₩215.3b |
A214680 DRTECH | 2.5x | n/a | ₩217.9b |
A150840 IntroMedic | 27.9x | n/a | ₩223.7b |
Price-To-Sales vs Peers: Insufficient data to calculate A150840's Price-To-Sales Ratio vs. peers for valuation analysis.
Price to Earnings Ratio vs Industry
How does A150840's PE Ratio compare vs other companies in the KR Medical Equipment Industry?
Price-To-Sales vs Industry: A150840 is expensive based on its Price-To-Sales Ratio (27.9x) compared to the KR Medical Equipment industry average (3x).
Price to Sales Ratio vs Fair Ratio
What is A150840's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 27.9x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate A150840's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.